NCT05438316 - Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

August 2, 2022

Study Completion Date

November 17, 2022

Conditions

Bioequivalence

Interventions

DRUG

Ramipril tablet 10 mg

Ramipril is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 10 mg of ramipril.

DRUG

Tritace® tablet 10 mg

Tritace® is manufactured by Sanofi-Aventis Deutschland GmbH, Germany. Each tablet contains 10 mg of ramipril.

Trial Locations (1)

Ligand Research LLC, Moscow